Reply to Kobayashi : Too Premature to Deny the Potential of Thrombomodulin Alfa in Idiopathic Pulmonary Fibrosis.
作者信息
Kondoh Yasuhiro, Azuma Arata, Tagawa Jun, Yamamori Natsuki, Homma Sakae
机构信息
Tosei General HospitalAichi, Japan.
Nippon Medical SchoolTokyo, Japan.
出版信息
Am J Respir Crit Care Med. 2020 Jun 1;201(11):1450-1451. doi: 10.1164/rccm.202002-0398LE.
Abstract
摘要
相似文献
1
Reply to Kobayashi : Too Premature to Deny the Potential of Thrombomodulin Alfa in Idiopathic Pulmonary Fibrosis.对小林的回复：现在就否定α-血栓调节蛋白治疗特发性肺纤维化的潜力还为时过早。
Am J Respir Crit Care Med. 2020 Jun 1;201(11):1450-1451. doi: 10.1164/rccm.202002-0398LE.
2
Too Premature to Deny the Potential of Thrombomodulin Alfa in Idiopathic Pulmonary Fibrosis.过早否定重组血栓调节蛋白在特发性肺纤维化中的治疗潜力为时尚早。
Am J Respir Crit Care Med. 2020 Jun 1;201(11):1449-1450. doi: 10.1164/rccm.202002-0271LE.
3
Thrombomodulin Alfa for Acute Exacerbation of Idiopathic Pulmonary Fibrosis. A Randomized, Double-Blind Placebo-controlled Trial.血栓调节蛋白 α 治疗特发性肺纤维化急性加重：一项随机、双盲、安慰剂对照试验。
Am J Respir Crit Care Med. 2020 May 1;201(9):1110-1119. doi: 10.1164/rccm.201909-1818OC.
4
Reply to Horita and Takeshi: Thrombomodulin Did Not Benefit Acute Exacerbation of Idiopathic Pulmonary Fibrosis in a Trial.对堀田和武志的回复：在一项试验中，血栓调节蛋白对特发性肺纤维化急性加重期并无益处。
Am J Respir Crit Care Med. 2020 Jul 1;202(1):151-152. doi: 10.1164/rccm.202003-0666LE.
5
Thrombomodulin Did Not Benefit Acute Exacerbation of Idiopathic Pulmonary Fibrosis in a Trial.在一项试验中，血栓调节蛋白对特发性肺纤维化急性加重期并无益处。
Am J Respir Crit Care Med. 2020 Jul 1;202(1):150-151. doi: 10.1164/rccm.202003-0494LE.
6
Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis. A Call to Arms.特发性肺纤维化急性加重的治疗。战斗的号角。
Am J Respir Crit Care Med. 2020 May 1;201(9):1030-1032. doi: 10.1164/rccm.202001-0057ED.
7
Therapeutic Role of Recombinant Human Soluble Thrombomodulin for Acute Exacerbation of Idiopathic Pulmonary Fibrosis.重组人可溶性血栓调节蛋白治疗特发性肺纤维化急性加重的作用。
Medicina (Kaunas). 2019 May 20;55(5):172. doi: 10.3390/medicina55050172.
8
Reply to Kobayashi : Adenine Nucleotide Translocases and Cellular Senescence in Idiopathic Pulmonary Fibrosis.对小林的回复：特发性肺纤维化中的腺嘌呤核苷酸转运体与细胞衰老
Am J Respir Cell Mol Biol. 2024 Mar;70(3):226-227. doi: 10.1165/rcmb.2023-0405LE.
9
Recombinant human soluble thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis: A historically controlled study.重组人可溶性血栓调节蛋白治疗特发性肺纤维化急性加重期：一项历史对照研究。
Respir Investig. 2018 Mar;56(2):136-143. doi: 10.1016/j.resinv.2017.10.004. Epub 2017 Dec 16.
10
Efficacy of thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia: a nonrandomized prospective study.血栓调节蛋白对特发性肺纤维化和非特异性间质性肺炎急性加重期的疗效：一项非随机前瞻性研究。
Drug Des Devel Ther. 2015 Oct 23;9:5755-62. doi: 10.2147/DDDT.S90739. eCollection 2015.
本文引用的文献
1
Thrombomodulin Alfa for Acute Exacerbation of Idiopathic Pulmonary Fibrosis. A Randomized, Double-Blind Placebo-controlled Trial.血栓调节蛋白 α 治疗特发性肺纤维化急性加重：一项随机、双盲、安慰剂对照试验。
Am J Respir Crit Care Med. 2020 May 1;201(9):1110-1119. doi: 10.1164/rccm.201909-1818OC.
2
Recombinant Human Thrombomodulin in Acute Exacerbation of Idiopathic Pulmonary Fibrosis.重组人血栓调节蛋白在特发性肺纤维化急性加重期的应用
Chest. 2015 Aug;148(2):436-443. doi: 10.1378/chest.14-2746.
3
Recombinant human soluble thrombomodulin treatment for acute exacerbation of idiopathic pulmonary fibrosis: a retrospective study.重组人可溶性血栓调节蛋白治疗特发性肺纤维化急性加重期：一项回顾性研究
Respiration. 2015;89(3):201-7. doi: 10.1159/000369828. Epub 2015 Feb 5.
4
Thrombomodulin for acute exacerbations of idiopathic pulmonary fibrosis: a proof of concept study.血栓调节蛋白用于特发性肺纤维化急性加重期：一项概念验证研究
Pulm Pharmacol Ther. 2014 Dec;29(2):233-40. doi: 10.1016/j.pupt.2014.04.008. Epub 2014 May 14.
5
An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.特发性肺纤维化：诊断和管理的循证指南（美国胸科学会/欧洲呼吸学会/日本呼吸学会/拉丁美洲胸科学会联合发布）
Am J Respir Crit Care Med. 2011 Mar 15;183(6):788-824. doi: 10.1164/rccm.2009-040GL.
Zotero 插件